Christopher Robert Sudfeld, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 84 | 2024 | 1387 | 5.470 |
Why?
|
Child Development | 34 | 2024 | 2306 | 4.520 |
Why?
|
Micronutrients | 18 | 2022 | 382 | 4.030 |
Why?
|
Dietary Supplements | 45 | 2024 | 3415 | 3.740 |
Why?
|
HIV Infections | 47 | 2024 | 17352 | 3.320 |
Why?
|
Premature Birth | 15 | 2024 | 1782 | 2.530 |
Why?
|
Cholecalciferol | 6 | 2024 | 553 | 2.170 |
Why?
|
Vitamin D Deficiency | 9 | 2022 | 1388 | 1.890 |
Why?
|
Infant Mortality | 11 | 2024 | 759 | 1.690 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2024 | 2151 | 1.640 |
Why?
|
Growth Disorders | 13 | 2024 | 655 | 1.450 |
Why?
|
Anemia, Iron-Deficiency | 8 | 2022 | 369 | 1.430 |
Why?
|
Mothers | 14 | 2023 | 2198 | 1.400 |
Why?
|
Tuberculosis, Pulmonary | 5 | 2020 | 832 | 1.380 |
Why?
|
Pregnancy | 61 | 2024 | 29876 | 1.370 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 160 | 1.320 |
Why?
|
Nutritional Status | 12 | 2023 | 1615 | 1.310 |
Why?
|
Maternal Nutritional Physiological Phenomena | 5 | 2024 | 389 | 1.300 |
Why?
|
Infant, Low Birth Weight | 7 | 2024 | 870 | 1.300 |
Why?
|
Infant | 75 | 2024 | 36193 | 1.300 |
Why?
|
Malnutrition | 9 | 2024 | 645 | 1.290 |
Why?
|
Vitamins | 15 | 2022 | 1635 | 1.280 |
Why?
|
Anti-Retroviral Agents | 6 | 2024 | 1784 | 1.220 |
Why?
|
Child Nutritional Physiological Phenomena | 5 | 2023 | 295 | 1.170 |
Why?
|
Rural Population | 19 | 2022 | 2285 | 1.160 |
Why?
|
Motor Skills | 4 | 2019 | 521 | 1.140 |
Why?
|
Vitamin A | 10 | 2022 | 613 | 1.130 |
Why?
|
Iron | 12 | 2024 | 1793 | 1.130 |
Why?
|
Vitamin D | 12 | 2022 | 3303 | 1.120 |
Why?
|
Developing Countries | 18 | 2024 | 2885 | 1.090 |
Why?
|
Adolescent Development | 2 | 2021 | 282 | 1.080 |
Why?
|
Folic Acid | 8 | 2022 | 1323 | 1.070 |
Why?
|
Pregnancy Complications | 5 | 2023 | 2947 | 1.070 |
Why?
|
Infant, Newborn | 52 | 2024 | 26198 | 1.060 |
Why?
|
Depression | 11 | 2023 | 8124 | 0.990 |
Why?
|
Stillbirth | 6 | 2023 | 368 | 0.980 |
Why?
|
Poverty | 7 | 2021 | 2697 | 0.970 |
Why?
|
Birth Weight | 10 | 2023 | 2103 | 0.930 |
Why?
|
Calcium, Dietary | 3 | 2024 | 529 | 0.900 |
Why?
|
Infant, Small for Gestational Age | 8 | 2024 | 461 | 0.900 |
Why?
|
CD4 Lymphocyte Count | 10 | 2024 | 2571 | 0.890 |
Why?
|
Thinness | 7 | 2023 | 490 | 0.890 |
Why?
|
Cognition | 12 | 2024 | 6992 | 0.860 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2024 | 1897 | 0.860 |
Why?
|
Child Nutrition Disorders | 2 | 2021 | 151 | 0.850 |
Why?
|
Child, Preschool | 56 | 2024 | 42231 | 0.850 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2022 | 52 | 0.840 |
Why?
|
Anemia | 10 | 2024 | 1509 | 0.830 |
Why?
|
Breast Feeding | 10 | 2024 | 1360 | 0.820 |
Why?
|
HIV Wasting Syndrome | 2 | 2013 | 99 | 0.820 |
Why?
|
Female | 135 | 2024 | 392688 | 0.800 |
Why?
|
Lactation | 5 | 2024 | 397 | 0.790 |
Why?
|
Zinc | 7 | 2024 | 690 | 0.780 |
Why?
|
Wasting Syndrome | 3 | 2021 | 99 | 0.780 |
Why?
|
Measles Vaccine | 2 | 2013 | 80 | 0.760 |
Why?
|
Intelligence | 3 | 2021 | 924 | 0.750 |
Why?
|
Milk, Human | 4 | 2023 | 486 | 0.740 |
Why?
|
Pregnancy Outcome | 8 | 2023 | 2922 | 0.730 |
Why?
|
Pregnant Women | 5 | 2023 | 566 | 0.730 |
Why?
|
Prenatal Care | 4 | 2023 | 1139 | 0.700 |
Why?
|
Double-Blind Method | 18 | 2023 | 12341 | 0.690 |
Why?
|
Pre-Eclampsia | 3 | 2024 | 1231 | 0.690 |
Why?
|
Opportunistic Infections | 2 | 2013 | 376 | 0.680 |
Why?
|
Income | 4 | 2021 | 1877 | 0.660 |
Why?
|
Humans | 168 | 2024 | 761578 | 0.660 |
Why?
|
Hypercalcemia | 1 | 2022 | 423 | 0.650 |
Why?
|
Unemployment | 2 | 2021 | 210 | 0.640 |
Why?
|
Prospective Studies | 34 | 2024 | 54423 | 0.640 |
Why?
|
Focus Groups | 1 | 2024 | 1413 | 0.630 |
Why?
|
Anti-HIV Agents | 9 | 2024 | 4527 | 0.620 |
Why?
|
Education, Nonprofessional | 1 | 2018 | 31 | 0.620 |
Why?
|
Child | 54 | 2024 | 80157 | 0.590 |
Why?
|
Punishment | 1 | 2018 | 95 | 0.590 |
Why?
|
Measles | 2 | 2010 | 183 | 0.580 |
Why?
|
Viral Load | 7 | 2024 | 3332 | 0.570 |
Why?
|
Young Adult | 41 | 2024 | 59254 | 0.550 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 583 | 0.550 |
Why?
|
Social Support | 2 | 2024 | 2171 | 0.540 |
Why?
|
Health Status | 6 | 2020 | 4077 | 0.530 |
Why?
|
Diarrhea | 7 | 2024 | 1318 | 0.520 |
Why?
|
Alanine Transaminase | 1 | 2019 | 603 | 0.520 |
Why?
|
World Health Organization | 2 | 2019 | 1322 | 0.520 |
Why?
|
Nutrition Policy | 2 | 2019 | 471 | 0.510 |
Why?
|
Morbidity | 8 | 2024 | 1751 | 0.500 |
Why?
|
Calcium | 4 | 2024 | 5722 | 0.490 |
Why?
|
Executive Function | 2 | 2021 | 1392 | 0.490 |
Why?
|
Male | 84 | 2024 | 360841 | 0.480 |
Why?
|
Weight Gain | 3 | 2024 | 2348 | 0.480 |
Why?
|
Adult | 63 | 2024 | 221200 | 0.470 |
Why?
|
Adolescent | 38 | 2024 | 88323 | 0.470 |
Why?
|
Fetal Development | 1 | 2020 | 769 | 0.460 |
Why?
|
Patient Discharge | 6 | 2024 | 3443 | 0.460 |
Why?
|
Anthropometry | 5 | 2023 | 1349 | 0.460 |
Why?
|
Tuberculosis | 4 | 2022 | 2017 | 0.460 |
Why?
|
Growth | 2 | 2016 | 365 | 0.460 |
Why?
|
Qualitative Research | 1 | 2024 | 3023 | 0.450 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 26127 | 0.450 |
Why?
|
Aftercare | 4 | 2024 | 914 | 0.440 |
Why?
|
Gestational Age | 3 | 2021 | 3577 | 0.440 |
Why?
|
Peer Group | 2 | 2024 | 692 | 0.440 |
Why?
|
Diet | 7 | 2021 | 8075 | 0.430 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2017 | 662 | 0.430 |
Why?
|
Mental Health | 4 | 2020 | 3250 | 0.430 |
Why?
|
Socioeconomic Factors | 15 | 2023 | 7827 | 0.430 |
Why?
|
Research | 1 | 2021 | 1982 | 0.420 |
Why?
|
Vitamin B 12 | 3 | 2020 | 524 | 0.400 |
Why?
|
Herpes Genitalis | 1 | 2013 | 150 | 0.400 |
Why?
|
Herpesvirus 2, Human | 1 | 2013 | 191 | 0.390 |
Why?
|
India | 8 | 2024 | 2348 | 0.390 |
Why?
|
Antibodies, Viral | 2 | 2013 | 3156 | 0.390 |
Why?
|
Ethiopia | 7 | 2022 | 464 | 0.380 |
Why?
|
Vitamin A Deficiency | 4 | 2017 | 88 | 0.380 |
Why?
|
Hemoglobins | 7 | 2022 | 1526 | 0.380 |
Why?
|
Selenium | 1 | 2014 | 417 | 0.370 |
Why?
|
Cohort Studies | 20 | 2024 | 41493 | 0.370 |
Why?
|
Risk Factors | 30 | 2024 | 74212 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2024 | 10212 | 0.350 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.340 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5440 | 0.340 |
Why?
|
Iron, Dietary | 2 | 2023 | 148 | 0.330 |
Why?
|
Serum Albumin | 1 | 2013 | 672 | 0.330 |
Why?
|
Infectious Disease Transmission, Vertical | 4 | 2022 | 1351 | 0.330 |
Why?
|
Prevalence | 15 | 2023 | 15732 | 0.320 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2019 | 352 | 0.320 |
Why?
|
Chickens | 2 | 2021 | 859 | 0.310 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 560 | 0.300 |
Why?
|
Niger | 3 | 2022 | 38 | 0.300 |
Why?
|
Vaccination | 2 | 2022 | 3384 | 0.290 |
Why?
|
Health Promotion | 2 | 2019 | 2214 | 0.290 |
Why?
|
Urban Population | 5 | 2024 | 2036 | 0.290 |
Why?
|
Weight Loss | 2 | 2022 | 2684 | 0.280 |
Why?
|
Brazil | 5 | 2021 | 1230 | 0.280 |
Why?
|
Fungi | 1 | 2009 | 338 | 0.280 |
Why?
|
Linear Models | 5 | 2021 | 5872 | 0.270 |
Why?
|
Mycoses | 1 | 2009 | 386 | 0.270 |
Why?
|
Liberia | 5 | 2024 | 174 | 0.270 |
Why?
|
Body Height | 6 | 2024 | 1570 | 0.260 |
Why?
|
Developmental Disabilities | 3 | 2019 | 1509 | 0.260 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2022 | 518 | 0.260 |
Why?
|
Pakistan | 2 | 2023 | 293 | 0.250 |
Why?
|
RNA, Viral | 1 | 2014 | 2846 | 0.250 |
Why?
|
Malawi | 4 | 2024 | 304 | 0.250 |
Why?
|
Chad | 1 | 2024 | 9 | 0.250 |
Why?
|
Incidence | 10 | 2020 | 21355 | 0.240 |
Why?
|
Dysentery | 1 | 2024 | 14 | 0.230 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2024 | 30 | 0.230 |
Why?
|
Animal Husbandry | 2 | 2021 | 64 | 0.220 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.220 |
Why?
|
Age Factors | 11 | 2021 | 18398 | 0.220 |
Why?
|
Africa South of the Sahara | 6 | 2023 | 744 | 0.210 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2518 | 0.210 |
Why?
|
Placebos | 2 | 2020 | 1667 | 0.210 |
Why?
|
Maternal Age | 4 | 2019 | 809 | 0.200 |
Why?
|
Child Mortality | 3 | 2024 | 205 | 0.200 |
Why?
|
Fetal Death | 1 | 2024 | 435 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.200 |
Why?
|
Disease Progression | 3 | 2022 | 13510 | 0.200 |
Why?
|
Anxiety | 1 | 2017 | 4573 | 0.200 |
Why?
|
China | 4 | 2021 | 2374 | 0.190 |
Why?
|
Body Mass Index | 7 | 2024 | 12953 | 0.190 |
Why?
|
Health Behavior | 4 | 2020 | 2644 | 0.190 |
Why?
|
Clinical Protocols | 2 | 2017 | 1440 | 0.190 |
Why?
|
Models, Theoretical | 3 | 2021 | 3575 | 0.190 |
Why?
|
Communication | 1 | 2015 | 3873 | 0.190 |
Why?
|
Nutritive Value | 2 | 2021 | 350 | 0.190 |
Why?
|
Sex Factors | 10 | 2022 | 10554 | 0.180 |
Why?
|
Treatment Outcome | 11 | 2022 | 64684 | 0.180 |
Why?
|
Peru | 3 | 2019 | 891 | 0.180 |
Why?
|
Education | 2 | 2021 | 537 | 0.180 |
Why?
|
Infant Nutrition Disorders | 2 | 2018 | 70 | 0.180 |
Why?
|
Antidiarrheals | 1 | 2020 | 46 | 0.180 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2022 | 296 | 0.180 |
Why?
|
Language Development | 2 | 2019 | 183 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2022 | 39107 | 0.180 |
Why?
|
Educational Status | 2 | 2019 | 2522 | 0.180 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1285 | 0.180 |
Why?
|
Azithromycin | 1 | 2021 | 199 | 0.180 |
Why?
|
Armenia | 1 | 2020 | 15 | 0.180 |
Why?
|
Growth Hormone | 1 | 2022 | 569 | 0.180 |
Why?
|
Survival Analysis | 3 | 2019 | 10090 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 369 | 0.160 |
Why?
|
Eggs | 1 | 2020 | 182 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12059 | 0.160 |
Why?
|
Immunoglobulins | 1 | 2022 | 852 | 0.160 |
Why?
|
Inflammation | 4 | 2024 | 10774 | 0.160 |
Why?
|
Maternal Behavior | 1 | 2021 | 307 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 413 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14607 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
Intelligence Tests | 1 | 2019 | 503 | 0.160 |
Why?
|
Financial Support | 1 | 2019 | 117 | 0.160 |
Why?
|
Administration, Oral | 3 | 2021 | 4021 | 0.150 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4853 | 0.150 |
Why?
|
Vietnam | 1 | 2019 | 409 | 0.150 |
Why?
|
Middle Aged | 21 | 2024 | 220917 | 0.150 |
Why?
|
Time Factors | 5 | 2021 | 39970 | 0.150 |
Why?
|
Quality of Life | 1 | 2020 | 13367 | 0.150 |
Why?
|
Ferritins | 4 | 2022 | 598 | 0.150 |
Why?
|
Botswana | 2 | 2022 | 1048 | 0.150 |
Why?
|
Mother-Child Relations | 1 | 2021 | 495 | 0.150 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 225 | 0.150 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2019 | 180 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2012 | 1722 | 0.150 |
Why?
|
House Calls | 1 | 2019 | 161 | 0.140 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12463 | 0.140 |
Why?
|
Perinatal Care | 1 | 2020 | 243 | 0.140 |
Why?
|
Single-Blind Method | 1 | 2021 | 1574 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1935 | 0.140 |
Why?
|
Overweight | 3 | 2024 | 2417 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6863 | 0.130 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3826 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6484 | 0.130 |
Why?
|
Psychotherapy, Group | 1 | 2020 | 412 | 0.130 |
Why?
|
Eating | 2 | 2021 | 1539 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1391 | 0.130 |
Why?
|
Schools | 2 | 2021 | 1489 | 0.130 |
Why?
|
Postpartum Period | 2 | 2020 | 1173 | 0.130 |
Why?
|
Communication Disorders | 1 | 2015 | 50 | 0.120 |
Why?
|
HIV | 1 | 2022 | 1582 | 0.120 |
Why?
|
School Health Services | 1 | 2019 | 384 | 0.120 |
Why?
|
Motor Skills Disorders | 1 | 2015 | 89 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7406 | 0.120 |
Why?
|
Research Design | 4 | 2019 | 6180 | 0.120 |
Why?
|
Program Evaluation | 2 | 2023 | 2495 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2017 | 302 | 0.120 |
Why?
|
Birth Intervals | 1 | 2014 | 51 | 0.120 |
Why?
|
Body Weight | 2 | 2015 | 4618 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2021 | 846 | 0.120 |
Why?
|
Lipids | 2 | 2022 | 3341 | 0.110 |
Why?
|
Community Health Services | 1 | 2019 | 656 | 0.110 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 257 | 0.110 |
Why?
|
Endemic Diseases | 1 | 2014 | 190 | 0.110 |
Why?
|
Community-Based Participatory Research | 2 | 2019 | 221 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 875 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1020 | 0.110 |
Why?
|
Hepatitis B | 1 | 2019 | 705 | 0.110 |
Why?
|
Sexual Behavior | 2 | 2019 | 2180 | 0.110 |
Why?
|
Social Class | 1 | 2021 | 2004 | 0.100 |
Why?
|
Antibody Affinity | 1 | 2013 | 246 | 0.100 |
Why?
|
Regression Analysis | 4 | 2016 | 6344 | 0.100 |
Why?
|
Caregivers | 2 | 2022 | 2238 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1010 | 0.100 |
Why?
|
Maternal Health Services | 1 | 2017 | 461 | 0.100 |
Why?
|
Goals | 1 | 2017 | 711 | 0.100 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 397 | 0.100 |
Why?
|
Wounds and Injuries | 3 | 2012 | 2491 | 0.100 |
Why?
|
Pneumonia | 2 | 2013 | 2143 | 0.100 |
Why?
|
Emotions | 3 | 2021 | 2739 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1618 | 0.100 |
Why?
|
Delivery, Obstetric | 1 | 2018 | 940 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 858 | 0.090 |
Why?
|
Dehydration | 2 | 2024 | 216 | 0.090 |
Why?
|
Family Planning Services | 1 | 2014 | 268 | 0.090 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.090 |
Why?
|
Parity | 1 | 2014 | 927 | 0.090 |
Why?
|
Family | 1 | 2021 | 3194 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4061 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2010 | 101 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4016 | 0.090 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2010 | 364 | 0.080 |
Why?
|
Ascorbic Acid | 1 | 2013 | 655 | 0.080 |
Why?
|
Ghana | 2 | 2022 | 315 | 0.080 |
Why?
|
Social Behavior | 1 | 2016 | 1135 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1584 | 0.080 |
Why?
|
Infant Food | 2 | 2019 | 140 | 0.080 |
Why?
|
Body Weights and Measures | 2 | 2019 | 208 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2707 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5492 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2010 | 227 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1879 | 0.080 |
Why?
|
Vitamin E | 1 | 2013 | 872 | 0.080 |
Why?
|
Students | 1 | 2019 | 1741 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10766 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2901 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3052 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4544 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2927 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1157 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1936 | 0.070 |
Why?
|
Risk Assessment | 4 | 2024 | 23996 | 0.070 |
Why?
|
Hospitalization | 2 | 2016 | 10721 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4028 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2012 | 1836 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4761 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2009 | 1682 | 0.060 |
Why?
|
Malaria | 1 | 2014 | 1227 | 0.060 |
Why?
|
Forced Expiratory Volume | 1 | 2009 | 1814 | 0.060 |
Why?
|
Child Care | 1 | 2024 | 124 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2019 | 80646 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2019 | 2696 | 0.050 |
Why?
|
Learning | 2 | 2021 | 1740 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12947 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 3980 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
Child Nutrition Sciences | 1 | 2020 | 22 | 0.050 |
Why?
|
Isoniazid | 1 | 2022 | 283 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6845 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1881 | 0.050 |
Why?
|
Aged | 6 | 2022 | 169308 | 0.040 |
Why?
|
Diarrhea, Infantile | 1 | 2020 | 100 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7237 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3683 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6426 | 0.040 |
Why?
|
MEDLINE | 1 | 2019 | 119 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 978 | 0.040 |
Why?
|
Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 283 | 0.040 |
Why?
|
Orosomucoid | 1 | 2018 | 45 | 0.040 |
Why?
|
Food, Fortified | 1 | 2019 | 190 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Exercise | 3 | 2019 | 5890 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2019 | 144 | 0.040 |
Why?
|
Colombia | 1 | 2019 | 282 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2019 | 163 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58983 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1162 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 651 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1702 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 416 | 0.030 |
Why?
|
Minerals | 1 | 2017 | 283 | 0.030 |
Why?
|
Trace Elements | 1 | 2017 | 195 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 540 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2016 | 168 | 0.030 |
Why?
|
Child Behavior | 1 | 2021 | 847 | 0.030 |
Why?
|
Economics | 1 | 2016 | 141 | 0.030 |
Why?
|
Term Birth | 1 | 2016 | 138 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 935 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 907 | 0.030 |
Why?
|
Diet Records | 1 | 2016 | 427 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 410 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2199 | 0.030 |
Why?
|
Asia | 1 | 2016 | 619 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 291 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 1004 | 0.030 |
Why?
|
Disabled Children | 1 | 2017 | 251 | 0.030 |
Why?
|
Pregnancy, Multiple | 1 | 2015 | 215 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 7967 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1375 | 0.030 |
Why?
|
Birth Order | 1 | 2014 | 95 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 635 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1709 | 0.030 |
Why?
|
Violence | 1 | 2019 | 937 | 0.030 |
Why?
|
United States | 2 | 2019 | 72335 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2107 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 504 | 0.030 |
Why?
|
Food Supply | 1 | 2019 | 544 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 128 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 907 | 0.030 |
Why?
|
Attention | 1 | 2022 | 2396 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2017 | 761 | 0.020 |
Why?
|
Prognosis | 1 | 2013 | 29629 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22176 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2775 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 736 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3205 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20099 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1541 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3271 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2176 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3065 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1188 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13255 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9610 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3093 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168475 | 0.010 |
Why?
|
Health Policy | 1 | 2010 | 2684 | 0.010 |
Why?
|